Company / Operating Income
Nuo Therapeutics, Inc. Operating Income History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$15.5M
FY2017
5-year range
-$41.3M / -$5.5M
FY2013-FY2017
Trend
-184.6%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$41M to -$16M over the past 2 years.
Based on SEC 10-K filings.
-$16M in FY2017.
Improved from -$41M to -$16M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, operating income decreased 184.6% year-over-year.
- Peak operating income was recorded in FY2011.
- Lowest operating income in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$15.5M | -184.6% |
| FY2016 | -$5.5M | +86.8% |
| FY2015 | -$41.3M | -76.6% |
| FY2014 | -$23.4M | -29.3% |
| FY2013 | -$18.1M | -40.3% |
| FY2012 | -$12.9M | -266.9% |
| FY2011 | -$3.5M | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026